At HN we specialise in the practical application of population health management, by identifying high-cost, high-need patients, and supporting them to improve their outcomes and reduce their care consumption.

Our team of clinicians, academics, researchers and ex-NHS staff are led by Mark England, CEO, who led one of the first integrated NHS care systems and its transformation. In addition, HN’s Founder Dr Joachim Werr is an ED clinician with wide-ranging experience including in academia and having worked in world-renowned consultancies. Our team has extensive experience and expertise to support you in the transition to Predictive Health and Care.

The challenge for healthcare

At HN we believe the emphasis in healthcare should be on providing proactive care that prevents admissions, rather than reactive care that treats. This is the only way to create a truly sustainable healthcare system for the long-term. Data-driven approaches can both find and prevent exacerbations and unplanned care events that occupy so much of clinical capacity around the world.

How it works

HN Population Health Management supports the local configuration, implementation, and evaluation of HN’s products, HN Predict and HN Virtual Wards.

The starting point is to understand your objectives and definition of success. We will work together to understand your system’s context, readiness, and capabilities. By using easy to understand clinical pathways and redesign methods and frameworks, we will help you design the journey, identify the risks and opportunities, and provide the continued leadership required to reach your goal and celebrate success.

Our evidence

We support a number of Integrated Care Systems, local Provider Collaboratives and individuals Primary Care Networks to implement Predictive and Preventive Care.

See our case studies

Providing all advisory support for you to implement predictive and preventive healthcare
Analysing and understanding the dynamism in unplanned care
Stratifying populations based on amenable risk
Focusing on the 1-5% most high consuming patients who account for 50-75% of resources
Measuring and publishing impact in peer reviewed journals
Providing both data scientific, clinical and digital capabilities